Antibody–Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review

Overview of attention for article published in Targeted Oncology, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#10 of 610)
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 1 news outlet
twitter: 3 X users

patent: 3 patents

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 40 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Binding molecules against BCMA and uses thereof

Grant US-11492409-B2

United States of America

anti-CD56 antibody-drug conjugates and their use in therapy

Application FR-3107648-A1

France

ANTI-CD56 ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY

Application WO-2021170961-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.